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Purpose. To evaluate the role of corneal epithelium in riboflavin/ultraviolet-A (UVA) mediated corneal collagen cross-linking
treatment. Methods. Fifty New Zealand rabbits were divided into 5 groups: UVA treatment with or without corneal epithelium,
UVA+riboflavin treatment with or without corneal epithelium, and control without any treatment. All rabbits were sacrificed after
irradiation and subsequently 4mm×10mm corneal strips were harvested for biomechanical evaluation. Results. UVA irradiation
alone did not enhance the maximal stress and Young’s modulus of corneal specimens with (3.15±0.56mpa, 1.00±0.09mpa) or
without (3.53±0.85mpa, 0.94±0.21mpa) the corneal epithelium, compared to specimens in the control group (4.30±0.68mpa,
1.03±0.24mpa). However, UVA irradiation combined with riboflavin significantly increased the maximal stress and Young’s
modulus of corneal specimens with (5.27±1.09mpa, 1.23±0.23mpa, 𝑃 < 0.05) or without (7.16±1.88mpa, 1.42±0.16mpa,
𝑃 < 0.05) corneal epithelium when compared to the control group. The maximal stress and Young’s modulus of cornea in
UVA+riboflavin and “epithelium-off” group were 35.9% and 15.4% higher compared to the UVA+riboflavin and “epithelium-on”
group,respectively(𝑃 < 0.05).Conclusions.OurstudyshowsthatUVA+riboflavintreatmentsignificantlyaffectsthebiomechanical
properties of the cornea with and without epithelial removal. However, corneas without epithelium seem to benefit more compared
to corneas with the epithelium.
1. Introduction
K e r a t o c o n u si san o n i n fl a m m a t o r y ,c h r o n i cp r o g r e s s i v e
corneal disorder with an incidence of approximately 1 in
2,000 [1]. The clinical signs of keratoconus include stromal
thinning followed by a cone-like protrusion of the cornea,
w h i c hi nt u r ni n d u c e sp r o g r e s s i v ei r r e g u l a ra s t i g m a t i s m .I n
late stages of keratoconus, breaks in the Descemet’s layer
may lead to acute corneal hydrops which aggravates visual
impairment. Common treatments included contact lenses
and glasses, intracorneal rings, photorefractive keratectomy
(PRK), and corneal transplantation [2, 3]. However, these
treatment modalities do not retard or terminate the progres-
sion of keratoconus.
In 2003, Wollensak et al. reported riboflavin/ultraviolet-
A-(UVA)inducedcollagencross-linking(CXL)forstabiliza-
tion of keratoconus [4]. In Wollensak’s study, 70% of the eyes
hada2.01dioptersreductioninkeratometryand1.14diopters
reduction in refraction. An additional 60% of the eyes had
a slight improvement in visual acuity. The transparency of
the cornea and the lens, endothelial density, and intraocular
pressure remained unchanged. The study demonstrated that
cross-linking is a viable treatment modality that impedes the
progression of keratoconus [4]. It was further demonstrated
in an experimental model that riboflavin-UVA-induced col-
l a g e nc r o s s - l i n k i n gl e dt oa ni n c r e a s ei nm e c h a n i c a lr i g i d i t y
in porcine corneas and an even greater increase in human
corneas [5].2 BioMed Research International
The conventional protocol for CXL is to remove the
corneal epithelium before UVA irradiation. Previous stud-
ies [6–8] have demonstrated an enhancement of riboflavin
penetration into the corneal stroma after removal of corneal
epithelium. In the current study, we aim to determine the
role of corneal epithelium in CXL by comparative evalua-
tion of biomechanical properties of cornea after riboflavin/
ultraviolet-A-inducedCXLtreatmentwithorwithoutcorneal
epithelium.
2. Methods
2.1. Animal Model. Fifty New Zealand rabbits (weight 2.0–
2.5kg, age 4-5 months), acquired from the Shandong
Academy of Agricultural Sciences, were divided into 5
groups: UVA with (UVA epi-on) or without (UVA epi-
off) corneal epithelium, UVA+riboflavin with (CXL epi-on)
or without (CXL epi-off) corneal epithelium, and controls
(without any treatment). The living environment of the
experimental animals was maintained at 21
∘Cw i t ha1 2 - h o u r
l i g h ta n dd a r kc y c l e .A l lr a b b i t sw e r ef e da dl i b i t u m .A n i m a l s
used in this study were treated in accordance with the Shan-
dong University Animal Experimentation Ethic Committee
(AEEC) guidelines. The study protocol was approved by the
AEEC. All treatments were performed on the left eyes only.
2.2. Collagen Cross-Linking. The animals were anesthetized
with intramuscular injection of 0.2-0.3mL/kg xylazine (Hua
Mu Animal Health Products, China) and intravenous injec-
tion with 0.5mL diazepam (Jin Yao Amino Acid, China).
Baseline thickness of the cornea was measured using a
cornealpachymeter(DGH550,DGHTechnologyInc.,USA).
In the epi-off groups, central 8.5mm corneal epithelium was
scraped off with a scalpel. 0.1% riboflavin sodium phosphate
was prepared by dissolving riboflavin sodium phosphate
solution(Jiang’XipharmaceuticalCo.Ltd.,China)indistilled
water. Distilled water was used instead of riboflavin in the
control group. Riboflavin solution or distilled water (control
group) was topically administered onto the cornea for a
periodof30minutesatanintervalof2minutes.Subsequently,
the cornea was illuminated with an ultraviolet light for
30 minutes using a UVA lamp (UVX 1000 system, IROC
Innocross AG Co. Ltd., Switzerland) (wavelength 365nm,
irradiance 3.0mW/cm
2, total dose 5.4J/cm
2). Riboflavin
administration was continued every 2 minutes during UV
i l l u m i n a t i o n .Th es a m es u r g i c a lp r o c e d u r ew a su n d e r t a k e n
in the epithelium-on group without removal of the corneal
epithelium.
2.3. Evaluation of Corneal Biomechanical Properties. The
rabbits were sacrificed by air embolism immediately after
cross-linking procedure. For the preparation of the corneal
strips, corneoscleral ring of the enucleated eyes was cut off in
ac i r c u l a rm a n n e ra n da4 . 0m m× 10.0mm vertical corneal
strip was removed from the 12 o’clock position with a scalpel.
The corneal thickness was determined using a mechani-
cal micrometer caliper. The corneal strips were clamped
horizontally between the jaws of a commercially available
microcomputer-controlled biomaterial-testing device with a
distance of 8.0mm (𝐿0) between the jaws (Instron 5544
system,InstronCo.Ltd.,USA)(Figure1).Thestraindisplace-
mentwasincreasedlinearlyatarateof2.0millimeter/minute
and was measured up to the point of tissue rupture. A curve
for relationship between the load (𝐹) and displacement (Δ𝐿)
was obtained. As suggested previously [9], the data in the
range of 0–0. 04N were selected to calculate the stress (𝜎)
usingtheequation𝜎=𝐹 / 4 𝑡 ,wh er e𝑡isthecornealthickness,
and the related strain was obtained by 𝜀 = Δ𝐿/𝐿0.Y o u n g ’ s
modulus (𝐸) was calculated by using the equation 𝐸=
𝑑𝜎/𝑑𝜀 = 𝐴 ⋅ 𝐵exp(𝐵 × 𝜀).Th eu l t i m a t es t r e s sw a sm e a s u r e d
at the tearing point. The ultimate strain was measured as a
percentage of the starting length of the strip, represented by
t h ea m o u n to fe l o n g a t i o na tt h ep o i n to ft i s s u er u p t u r e .
H e m a t o x y l i na n de o s i n( H&E )s t a i n i n gw a su s e dt o
verify the success of epithelial removal and the presence of
an intact Descemet’s membrane.
2.4. Statistical Analysis. One way ANOVA was performed
with MedCalc (Version 9.6.2.0) to compare the difference
of maximal stress and Young’s modulus between different
groups.
3. Results
The average corneal thickness before epithelial debridement
was 361 ± 15𝜇m. There were no significant differences
between the baseline central corneal thicknesses before UVA
treatment in any of the groups. Histopathological analysis
showed a successful removal of corneal epithelium in speci-
fiedgroupsandanintactDescemet’smembraneinallsamples
(Figure 2).
UVA irradiation alone did not enhance the maximal
stressandYoung’sModulusofcornealspecimenswith(3.15±
0.56mpa,1.00±0.09mpa)orwithout(3.53±0.85mpa,0.94±
0.21mpa) corneal epithelium compared to the specimens
in the control group (4.30 ± 0.68mpa, 1.03 ± 0.24mpa)
(Figures 3 and 4). However, UVA irradiation combined with
riboflavin significantly increased the maximal stress and
Young’smodulusofcornealspecimenswith(5.27±1.09mpa,
1.23 ± 0.23mpa, 𝑃 < 0.05) or without (7.16 ± 1.88mpa, 1.42 ±
0.16mpa, 𝑃 < 0.05)t h ec o r n e a le p i t h e l i u mc o m p a r e dt o
the control group (Figures 3 and 4). The maximal stress and
Young’s modulus of cornea in UVA+riboflavin+epithelium-
off group were 35.9% and 15.4% higher compared to the
UVA+riboflavin+epithelium-on group, respectively (𝑃<
0.05).
4. Discussion
As a soft biological tissue, cornea shares some properties of
viscoelastic materials which can be evaluated by stress-strain
curve, Young’s modulus, and corneal hysteresis. Young’s
modulus is a major indicator of the elastic properties of
cornea.Itreflectstheabilityofacorneatoreturntoitsoriginal
shape after being under stress. It has also been proposedBioMed Research International 3
(a) (b)
Figure 1: Evaluation of biomechanical properties of corneal strips was carried out on Instron 5544 system.
Control UVA+rib+epi UVA+rib+nonepi
Figure2:Histopathologicalanalysisshowedasuccessfulremovalofcornealepithelialcellsinspecifiedgroups,withtheintegrityofDescemet’s
membrane (Hematoxylin eosin staining).
to reflect the severity of corneal ectatic disorders such as
keratoconus [10].
The last decade has seen a prominent increase in the
popularity of CXL as a therapeutic measure to retard the
progression of keratoconus. The stiffening of the upper 200–
300𝜇mo ft h ec o r n e a ls t r o m ai sa c h i e v e dt h r o u g hap h o -
tooxidative induction of collagen cross-links. The evidence
of efficacy of CXL is supported by laboratory studies docu-
menting the biomechanical and cellular changes induced by
cross-linking[11,12],aswellassatisfyingoutcomesofCXLin
theclinicalpractice[4,13,14].Animalstudieshaveelaborated
that changes in the biomechanical properties of cornea after
C X Lw e r er e l a t e dt ot h ei r r a d i a t i o nt i m e[ 15], light energy
density, and riboflavin absorption [16], as well as animal
species as evident by a greater increase of cornea rigidity in
humans compared to porcine corneas [5]. Besides the opti-
m i z e dU V Aa n dr i b o fl a v i ns o l u t i o np a r a m e t e r s ,t h es t a n d a r d
protocol for CXL [17]i n v o l v e st h er e m o v a lo fc e n t r a l9m m
of corneal epithelium before riboflavin administration, and
UVAirradiation.Recently,Kymionisetal.havedemonstrated
better visual and refractive outcomes after CXL combined
with epithelial removal using t-PTK than after mechanical
epithelial debridement [18].
However, considering the complications associated with
the removal of corneal epithelium, most notably pain, risk
of infection and postoperative corneal haze, an evaluation
of the necessity of this step during CXL is desirable in
clinical practice. Some surgeons have modified the standard
protocol and performed the treatment without removing the
epithelium [19–22]. In a study by Wollensak and Iomdina
[23], there was a statistically significant increase in Young’s
modulus in corneas treated with standard CXL as compared
to the epithelium-on corneas cross-linked with the addi-
tion of benzalkonium chloride-containing proxymetacaine
eye drops. The authors proposed that corneal cross-linking
without epithelial debridement reduced the biomechanical
effectbyapproximatelyone-fifthcomparedtostandardcross-
linking probably due to restricted and inhomogeneous stro-
maldistributionofriboflavin.Baiocchietal.[24]showedthat
stromal concentrations of riboflavin increased with exposure
time only if the corneal epithelium was removed. In our
study we found a statistically significant increase in Young’s
m o d u l u sa sw e l la st h em a x i m a ls t r e s si nb o t he p i t h e l i u m -
“on” and “-off” corneas. Further, we found that the maximal
stress and Young’s modulus of the corneal specimens in
the epithelium-off group were 35.9% and 15.4% higher,
respectively, than those in the epithelium-on group after
riboflavin and UVA combination treatment. The enhanced
effect of CXL in corneas without the epithelium is expected4 BioMed Research International
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Figure 3: UVA irradiation alone did not enhance the maximal
stress of cornea in epithelium-on (3.15 ± 0.56mpa) or epithelium-
off (3.53 ± 0.85mpa) groups compared with those in control group
(4.30 ± 0.68mpa). The UVA irradiation combined with riboflavin
significantly increased the maximal stress of cornea in epithelium-
on (5.27 ± 1.09mpa) or epithelium-off (7.16 ± 1.88mpa) groups
compared with those in control group (𝑃 < 0.05). The maximal
stress of cornea in UVA+rib+nonepi group is 35.9% higher than
that in UVA+rib+epi group (𝑃 < 0.05). Asterisk denotes significant
difference with control group, unless otherwise specified.
duetotheabsenceofanin tactepitheliumintheseeyeswhich
would otherwise impair the absorption of riboflavin [7].
K i s s n e re ta l .[ 25] found that treatment with benzalko-
nium chloride 0.02% induces sufficient epithelial permeabil-
ity for the passage of riboflavin as compared to the standard
protocol. Raiskup et al. [26] demonstrated that addition of
0.01% benzalkonium chloride and 0.44% sodium chloride
t or i b o fl a v i ns o l u t i o np r o m o t e si t sp e r m e a b i l i t yt h r o u g h
the epithelium, resulting in a sufficient concentration of
riboflavininthecornealstroma.Inadditiontothepermeabil-
ity issues of riboflavin through an intact corneal epithelium,
thepresenceofepitheliumrepresentsabarrierforUV Apene-
trationwhichisessentialforasuccessfulCXLprocedure.Itis
possible that the UVA energy delivered through “epithelium-
on” is different compared to the standard “epithelium-off”
procedure [27].
In our study, the morphological analysis using H & E
staining showed that the density of keratocytes and collagen
fibers had no significant changes in CXL groups with or
without corneal epithelium compared with that in control
group (data not shown here). Mencucci et al. [11]r e p o r t e d
that the diameter of corneal collagen fiber in CXL treated
human corneal buttons increased by 22.6% compared with
that in control group at 6 months postoperatively. In the
present study, the corneas were harvested within 1 hour after
CXL treatment, and therefore the pathological changes of
cornea could not be identified with techniques used in our
study. Considering the significant enhancement of corneal
biomechanical properties in the very early stage after CXL,
more specific and sensitive markers should be investigated to
evaluatethepathologicalchangesofcorneaimmediatelyafter
CXL treatment. Few clinical studies [28, 29]h a v ea t t e m p t e d
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Figure 4: UVA irradiation alone did not enhance Young’s modulus
of cornea in epithelium-on (1.00 ± 0.09mpa) or epithelium-off
(0.94 ± 0.21mpa) groups compared with those in control group
(1.03 ± 0.24mpa). The UVA irradiation combined with riboflavin
significantly increased Young’s modulus of cornea in epithelium-
on (1.23 ± 0.23mpa) or epithelium-off (1.42 ± 0.16mpa) groups
compared with those in control group (𝑃 < 0.05). Young’s modulus
of cornea in UVA+rib+nonepi group is 15.4% higher than that
in UVA+rib+epi group (𝑃 < 0.05). Asterisk denotes significant
difference with control group, unless otherwise specified.
to evaluate the safety and efficacy of transepithelial CXL in
caseswithkeratoconus.However,thesestudiesarelimitedby
small sample size, limited follow-up, and lack of comparative
groups.
There are a few limitations of the present study. Corneas
were retrieved early after the CXL procedure. Distilled
water was used as a solvent for riboflavin in our study to
match the control groups, as opposed to dextran which
is being used in the commercial preparation of riboflavin.
Application of hypotonic riboflavin solution without dextran
during cross-linking procedure may alter the permeability of
riboflavin and therefore lead to different results as compared
to the standard riboflavin/dextran solution. Exposure of
corneal epithelium to hyposmolar distilled water for 30
minutesmaycompromisethecell-celltightjunctionintegrity
thereby potentially increasing permeability to the riboflavin
solution [30]. This may explain a significantly improved
biomechanical response compared with the control in our
study even with an intact corneal epithelium (albeit less
than that produced following epithelial removal). We did not
evaluate the permeability of the riboflavin solution into the
corneal stroma. Future studies can focus on evaluation of
biomechanical properties of the corneas using other carriers
whicharebeingusedfortransepithelialCXL.Itisnoteworthy
that the rabbit cornea lacks Bowman’s membrane which is a
possible barrier for the permeation of riboflavin during CXL
procedure. Further studies should evaluate whether injury to
theBowman’smembraneduringepithelialremovalwillaffect
t h eo u t c o m eo fC X L .A l s o ,t h er a b b i tc o r n e a si nt h e i rs t u d y
were normal and not keratoconic.
Our study provides direct evidence of the effect of CXL
procedure on corneal biomechanical properties. This effectBioMed Research International 5
was significantly enhanced after the removal of corneal
epithelium during CXL.
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